{"transactions":[{"id":890208,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65377,"kind":"person","name":"Ryali Sriram","position":1,"cik":"0001762893","reported_name":"Ryali Sriram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to purchase Common Stock","published_at":"2026-02-20T22:26:37.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":247500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48 of the total number of shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2030, subject to the reporting person continuing to provide service to\nthe Issuer through each such vesting date."}],"balance_after":247500,"derivative":{"exercise_price":1.8,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":247500},"source":{"system":"sec-edgar","filing":"0001762893-26-000002","document":"wk-form4_1771626395.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000176289326000002/wk-form4_1771626395.xml","form_type":"4"}},{"id":890207,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65377,"kind":"person","name":"Ryali Sriram","position":1,"cik":"0001762893","reported_name":"Ryali Sriram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-20T22:26:37.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects restricted stock units (\"RSUs\") that vest in four equal annual installments beginning on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date."}],"balance_after":72360,"source":{"system":"sec-edgar","filing":"0001762893-26-000002","document":"wk-form4_1771626395.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000176289326000002/wk-form4_1771626395.xml","form_type":"4"}},{"id":1290541,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65377,"kind":"person","name":"Ryali Sriram","position":1,"cik":"0001762893","reported_name":"Ryali Sriram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-30T21:02:12.000Z","date":"2025-01-29","kind":"purchase","planned":false,"acquired":true,"shares":17360,"price":1.42,"value":24651.2,"ownership":{"direct":true},"balance_after":17360,"source":{"system":"sec-edgar","filing":"0001762893-25-000009","document":"wk-form4_1738270924.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000176289325000009/wk-form4_1738270924.xml","form_type":"4"}},{"id":1304875,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65377,"kind":"person","name":"Ryali Sriram","position":1,"cik":"0001762893","reported_name":"Ryali Sriram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to purchase Common Stock","published_at":"2025-01-10T22:06:04.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on January 2, 2026, and the remaining shares subject to the option shall vest monthly thereafter (1/48 of the shares per month for the 36 months following January 2, 2026), subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":300000,"derivative":{"exercise_price":1.64,"expiration_date":"2035-01-09","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001762893-25-000006","document":"wk-form4_1736546757.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000176289325000006/wk-form4_1736546757.xml","form_type":"4"}},{"id":1696227,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":65377,"kind":"person","name":"Ryali Sriram","position":1,"cik":"0001762893","reported_name":"Ryali Sriram","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-03T02:24:26.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":314125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable with respect to 1/3rd of the shares subject thereto on the first anniversary of the grant date, and with respect to 1/36th of the original number of shares subject thereto on each monthly anniversary thereafter, subject to the Reporting Person's continued employment through the applicable vesting dates."}],"balance_after":314125,"derivative":{"exercise_price":3.05,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":314125},"source":{"system":"sec-edgar","filing":"0000905148-24-000032","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000090514824000032/form4.xml","form_type":"4"}},{"id":1696226,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":65377,"kind":"person","name":"Ryali Sriram","position":1,"cik":"0001762893","reported_name":"Ryali Sriram","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-03T02:24:26.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":52350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest as to 1/3rd of the shares on each annual anniversary of the grant date, subject to the Reporting Person's continued employment through the applicable vesting dates."}],"balance_after":175791,"source":{"system":"sec-edgar","filing":"0000905148-24-000032","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000090514824000032/form4.xml","form_type":"4"}},{"id":1782780,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":65377,"kind":"person","name":"Ryali Sriram","position":1,"cik":"0001762893","reported_name":"Ryali Sriram","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-12T20:07:52.000Z","date":"2023-09-08","kind":"purchase","planned":false,"acquired":true,"shares":11650,"price":1.7044,"value":19856.26,"ownership":{"direct":true},"balance_after":123441,"source":{"system":"sec-edgar","filing":"0000905148-23-000903","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000090514823000903/form4.xml","form_type":"4"}},{"id":2015615,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":65377,"kind":"person","name":"Ryali Sriram","position":1,"cik":"0001762893","reported_name":"Ryali Sriram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-14T21:11:58.000Z","date":"2023-02-10","kind":"grant","acquired":true,"shares":372637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option was granted pursuant to the Issuer's 2022 Employment Inducement Award Plan and vests and becomes exercisable with respect to 25% of the shares subject thereto on February 10, 2024, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 10, 2027, in each case, subject to continued service through the applicable vesting date."}],"balance_after":372637,"derivative":{"exercise_price":5.86,"expiration_date":"2033-02-10","underlying":"Common Stock","underlying_shares":372637},"source":{"system":"sec-edgar","filing":"0001567619-23-002895","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000156761923002895/doc1.xml","form_type":"4"}},{"id":2015614,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":65377,"kind":"person","name":"Ryali Sriram","position":1,"cik":"0001762893","reported_name":"Ryali Sriram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-14T21:11:58.000Z","date":"2023-02-10","kind":"grant","acquired":true,"shares":111791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock. The shares vest as to one third of the shares on each yearly anniversary of the date of grant, provided that the Reporting Person provides continuous services to the Issuer as an employee, consultant, director or officer through each such vesting date."}],"balance_after":111791,"source":{"system":"sec-edgar","filing":"0001567619-23-002895","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000156761923002895/doc1.xml","form_type":"4"}},{"id":2335247,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":65377,"kind":"person","name":"Ryali Sriram","position":1,"cik":"0001762893","reported_name":"Ryali Sriram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-14T21:22:50.000Z","date":"2022-03-14","kind":"sale","acquired":false,"shares":2266,"price":5.5973,"value":12683.4818,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold by the reporting person in a pre-elected sell-to-cover transaction to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 14, 2022 for 5,417 shares."}],"balance_after":41566,"source":{"system":"sec-edgar","filing":"0001567619-22-006948","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000156761922006948/doc1.xml","form_type":"4"}},{"id":2337392,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":65377,"kind":"person","name":"Ryali Sriram","position":1,"cik":"0001762893","reported_name":"Ryali Sriram","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-11T21:06:51.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":143000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 48 equal monthly installments commencing on the grant date of March 11, 2022, subject to the Reporting Person's continuous service as of such date."}],"balance_after":143000,"derivative":{"exercise_price":5.1,"expiration_date":"2032-03-10","underlying":"Common Stock","underlying_shares":143000},"source":{"system":"sec-edgar","filing":"0001140361-22-009262","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000114036122009262/form4.xml","form_type":"4"}},{"id":2337391,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":65377,"kind":"person","name":"Ryali Sriram","position":1,"cik":"0001762893","reported_name":"Ryali Sriram","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-11T21:06:51.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying Restricted Stock Units award that will vest as to 33.3% on each of the first, second and third anniversaries of the grant date of March 11, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares purchased under the Issuer's Employee Stock Purchase Plans as follows: 434 shares on September 5, 2020, 585 shares on September 3, 2021, and 661 shares on March 5, 2022."}],"balance_after":43832,"source":{"system":"sec-edgar","filing":"0001140361-22-009262","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000114036122009262/form4.xml","form_type":"4"}},{"id":2621119,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":65377,"kind":"person","name":"Ryali Sriram","position":1,"cik":"0001762893","reported_name":"Ryali Sriram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-30T16:26:17.000Z","date":"2021-07-29","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments over 36 months measured from July 29, 2021 subject to Reporting Person's continuous service status as of each such date."}],"balance_after":30000,"derivative":{"exercise_price":8.15,"expiration_date":"2031-07-28","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001567619-21-014218","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000156761921014218/doc1.xml","form_type":"4"}},{"id":2718363,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":65377,"kind":"person","name":"Ryali Sriram","position":1,"cik":"0001762893","reported_name":"Ryali Sriram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-11T20:32:30.000Z","date":"2021-05-10","kind":"grant","acquired":true,"shares":87000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments over 48 months measured from May 10, 2021 subject to Reporting Person's continuous service status as of each such date."}],"balance_after":87000,"derivative":{"exercise_price":8.49,"expiration_date":"2031-05-09","underlying":"Common Stock","underlying_shares":87000},"source":{"system":"sec-edgar","filing":"0001209191-21-031905","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919121031905/doc4.xml","form_type":"4"}},{"id":2789037,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":65377,"kind":"person","name":"Ryali Sriram","position":1,"cik":"0001762893","reported_name":"Ryali Sriram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-15T19:38:18.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":97500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in equal monthly installments over 48 months measured from March 12, 2021 subject to Reporting Person's continuous service status as of each such date."}],"balance_after":97500,"derivative":{"exercise_price":9.99,"expiration_date":"2031-03-11","underlying":"Common Stock","underlying_shares":97500},"source":{"system":"sec-edgar","filing":"0001209191-21-020592","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919121020592/doc4.xml","form_type":"4"}},{"id":2789036,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":65377,"kind":"person","name":"Ryali Sriram","position":1,"cik":"0001762893","reported_name":"Ryali Sriram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-15T19:38:18.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":16250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying Restricted Stock Units award that will vest in three equal annual installments measured from March 12, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 274 shares acquired by the Reporting Person under the Issuer's Employee Stock Purchase Plan on March 5, 2021."}],"balance_after":18152,"source":{"system":"sec-edgar","filing":"0001209191-21-020592","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919121020592/doc4.xml","form_type":"4"}},{"id":3210797,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":65377,"kind":"person","name":"Ryali Sriram","position":1,"cik":"0001762893","reported_name":"Ryali Sriram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-13T17:35:56.000Z","date":"2020-03-12","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in equal monthly installments over 48 months measured from March 12, 2020 subject to Reporting Person's continuous service status as of each such date."}],"balance_after":65000,"derivative":{"exercise_price":5.6,"expiration_date":"2030-03-11","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-20-019001","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919120019001/doc4.xml","form_type":"4"}},{"id":3210796,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":65377,"kind":"person","name":"Ryali Sriram","position":1,"cik":"0001762893","reported_name":"Ryali Sriram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-13T17:35:56.000Z","date":"2020-03-05","kind":"grant","acquired":true,"shares":229,"price":7.31,"value":1673.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":1628,"source":{"system":"sec-edgar","filing":"0001209191-20-019001","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919120019001/doc4.xml","form_type":"4"}},{"id":3420424,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":65377,"kind":"person","name":"Ryali Sriram","position":1,"cik":"0001762893","reported_name":"Ryali Sriram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-09-06T17:47:58.000Z","date":"2019-09-05","kind":"grant","acquired":true,"shares":149,"price":9.367,"value":1395.683,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":1399,"source":{"system":"sec-edgar","filing":"0001209191-19-048805","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919119048805/doc4.xml","form_type":"4"}},{"id":3551392,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":65377,"kind":"person","name":"Ryali Sriram","position":1,"cik":"0001762893","reported_name":"Ryali Sriram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-22T21:34:51.000Z","date":"2019-04-22","kind":"purchase","acquired":true,"shares":1250,"price":11.0822,"value":13852.75,"ownership":{"direct":true},"balance_after":1250,"source":{"system":"sec-edgar","filing":"0001209191-19-025564","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919119025564/doc4.xml","form_type":"4"}},{"id":3703674,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":65377,"kind":"person","name":"Ryali Sriram","position":1,"cik":"0001762893","reported_name":"Ryali Sriram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option ( Right to Buy)","published_at":"2019-01-04T17:51:21.000Z","date":"2019-01-03","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% of the option shares on December 17, 2019 and vest as to the remaining shares in successive equal monthly installments for the subsequent 36 months subject to Reporting Person's continuous service status as of each such date."}],"balance_after":90000,"derivative":{"exercise_price":10.46,"expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-19-002201","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919119002201/doc4.xml","form_type":"4"}}]}